# ST JOE Co: financial statements, quarterly

JOE · NYSE · CIK 745308 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/joe.md) · [Financials](/companies/joe/financials.md) · [Filings](/companies/joe/filings.md) · [Insiders](/companies/joe/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/joe/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [101](/filings/0001558370-24-013522.md) | [86.7 d](/filings/0001104659-26-019676.md) | [87.8](/filings/0001558370-25-005281.md) | [112](/filings/0001558370-25-009454.md) | [99.0](/filings/0001104659-25-103742.md) | [104 d](/filings/0001104659-26-019676.md) | [94.2](/filings/0001104659-26-051523.md) | [129](/filings/0001104659-26-088152.md) | [161](/filings/0001104659-25-103742.md) | [129 d](/filings/0001104659-26-019676.md) | [99.0](/filings/0001104659-26-051523.md) | [159](/filings/0001104659-26-088152.md) |
| Gross profit | $m | not reported | not reported | [34.2](/filings/0001558370-25-005281.md) | [49.8](/filings/0001558370-25-009454.md) | [39.1](/filings/0001104659-25-103742.md) | [44.2 d](/filings/0001104659-26-019676.md) | [35.6](/filings/0001104659-26-051523.md) | [55.4](/filings/0001104659-26-088152.md) | [71.5](/filings/0001104659-25-103742.md) | [58.5 d](/filings/0001104659-26-019676.md) | [37.9](/filings/0001104659-26-051523.md) | [73.4](/filings/0001104659-26-088152.md) |
| Operating income | $m | [20.3](/filings/0001558370-24-013522.md) | [17.3 d](/filings/0001104659-26-019676.md) | [16.0](/filings/0001558370-25-005281.md) | [32.6](/filings/0001558370-25-009454.md) | [21.3](/filings/0001104659-25-103742.md) | [25.7 d](/filings/0001104659-26-019676.md) | [16.9](/filings/0001104659-26-051523.md) | [37.0](/filings/0001104659-26-088152.md) | [52.9](/filings/0001104659-25-103742.md) | [39.4 d](/filings/0001104659-26-019676.md) | [18.2](/filings/0001104659-26-051523.md) | [54.8](/filings/0001104659-26-088152.md) |
| Interest expense | $m | [8.4](/filings/0001558370-23-016723.md) | [8.8 d](/filings/0001558370-24-001435.md) | [8.6](/filings/0001558370-24-005603.md) | [8.5](/filings/0001558370-25-009454.md) | [8.4](/filings/0001104659-25-103742.md) | [8.1 d](/filings/0001104659-26-019676.md) | [7.8](/filings/0001104659-26-051523.md) | [7.8](/filings/0001104659-26-088152.md) | [7.8](/filings/0001104659-25-103742.md) | [7.2 d](/filings/0001104659-26-019676.md) | [7.1](/filings/0001104659-26-051523.md) | [6.9](/filings/0001104659-26-088152.md) |
| Income tax | $m | [6.8](/filings/0001558370-24-013522.md) | [4.3 d](/filings/0001104659-26-019676.md) | [4.6](/filings/0001558370-25-005281.md) | [8.3](/filings/0001558370-25-009454.md) | [6.4](/filings/0001104659-25-103742.md) | [6.6 d](/filings/0001104659-26-019676.md) | [5.8](/filings/0001104659-26-051523.md) | [9.9](/filings/0001104659-26-088152.md) | [13.7](/filings/0001104659-25-103742.md) | [9.7 d](/filings/0001104659-26-019676.md) | [4.5](/filings/0001104659-26-051523.md) | [14.1](/filings/0001104659-26-088152.md) |
| Net income | $m | [19.4](/filings/0001558370-24-013522.md) | [13.2 d](/filings/0001104659-26-019676.md) | [13.9](/filings/0001558370-25-005281.md) | [24.5](/filings/0001558370-25-009454.md) | [16.8](/filings/0001104659-25-103742.md) | [18.9 d](/filings/0001104659-26-019676.md) | [17.5](/filings/0001104659-26-051523.md) | [29.5](/filings/0001104659-26-088152.md) | [38.7](/filings/0001104659-25-103742.md) | [29.9 d](/filings/0001104659-26-019676.md) | [13.9](/filings/0001104659-26-051523.md) | [40.5](/filings/0001104659-26-088152.md) |
| Diluted EPS | $ per share | [0.33](/filings/0001558370-24-013522.md) | not reported | [0.24](/filings/0001558370-25-005281.md) | [0.42](/filings/0001558370-25-009454.md) | [0.29](/filings/0001104659-25-103742.md) | not reported | [0.30](/filings/0001104659-26-051523.md) | [0.51](/filings/0001104659-26-088152.md) | [0.67](/filings/0001104659-25-103742.md) | not reported | [0.24](/filings/0001104659-26-051523.md) | [0.71](/filings/0001104659-26-088152.md) |
| Basic EPS | $ per share | [0.33](/filings/0001558370-24-013522.md) | not reported | [0.24](/filings/0001558370-25-005281.md) | [0.42](/filings/0001558370-25-009454.md) | [0.29](/filings/0001104659-25-103742.md) | not reported | [0.30](/filings/0001104659-26-051523.md) | [0.51](/filings/0001104659-26-088152.md) | [0.67](/filings/0001104659-25-103742.md) | not reported | [0.24](/filings/0001104659-26-051523.md) | [0.71](/filings/0001104659-26-088152.md) |

- Revenue: us-gaap:Revenues
- Gross profit: us-gaap:GrossProfit
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [92.0](/filings/0001558370-24-013522.md) | [86.1](/filings/0001104659-26-019676.md) | [89.8](/filings/0001558370-25-005281.md) | [86.7](/filings/0001558370-25-009454.md) | [82.7](/filings/0001104659-25-103742.md) | [88.8](/filings/0001104659-26-019676.md) | [94.5](/filings/0001104659-26-051523.md) | [88.2](/filings/0001104659-26-088152.md) | [126](/filings/0001104659-25-103742.md) | [130](/filings/0001104659-26-088152.md) | [136](/filings/0001104659-26-051523.md) | [117](/filings/0001104659-26-088152.md) |
| Total assets | $m | [1,542](/filings/0001558370-23-016723.md) | [1,524](/filings/0001558370-25-001603.md) | [1,538](/filings/0001558370-24-005603.md) | [1,550](/filings/0001558370-24-010049.md) | [1,546](/filings/0001558370-24-013522.md) | [1,539](/filings/0001104659-26-019676.md) | [1,547](/filings/0001558370-25-005281.md) | [1,548](/filings/0001558370-25-009454.md) | [1,534](/filings/0001104659-25-103742.md) | [1,518](/filings/0001104659-26-088152.md) | [1,518](/filings/0001104659-26-051523.md) | [1,508](/filings/0001104659-26-088152.md) |
| Total liabilities | $m | [848](/filings/0001558370-23-016723.md) | [825](/filings/0001558370-25-001603.md) | [833](/filings/0001558370-24-005603.md) | [828](/filings/0001558370-24-010049.md) | [816](/filings/0001558370-24-013522.md) | [802](/filings/0001104659-26-019676.md) | [808](/filings/0001558370-25-005281.md) | [798](/filings/0001558370-25-009454.md) | [763](/filings/0001104659-25-103742.md) | [743](/filings/0001104659-26-088152.md) | [743](/filings/0001104659-26-051523.md) | [735](/filings/0001104659-26-088152.md) |
| Long-term debt | $m | [453](/filings/0001558370-23-016723.md) | [454](/filings/0001558370-25-001603.md) | [452](/filings/0001558370-24-005603.md) | [447](/filings/0001558370-24-010049.md) | [443](/filings/0001558370-24-013522.md) | [438](/filings/0001104659-26-019676.md) | [435](/filings/0001558370-25-005281.md) | [427](/filings/0001558370-25-009454.md) | [399](/filings/0001104659-25-103742.md) | [391](/filings/0001104659-26-088152.md) | [380](/filings/0001104659-26-051523.md) | [370](/filings/0001104659-26-088152.md) |
| Shareholders' equity | $m | [677](/filings/0001558370-23-016723.md) | [683](/filings/0001558370-25-001603.md) | [690](/filings/0001558370-24-005603.md) | [708](/filings/0001558370-24-010049.md) | [716](/filings/0001558370-24-013522.md) | [724](/filings/0001104659-26-019676.md) | [728](/filings/0001558370-25-005281.md) | [739](/filings/0001558370-25-009454.md) | [761](/filings/0001104659-25-103742.md) | [766](/filings/0001104659-26-088152.md) | [766](/filings/0001104659-26-051523.md) | [764](/filings/0001104659-26-088152.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [39.4 d](/filings/0001558370-24-013522.md) | [11.6 d](/filings/0001104659-26-019676.md) | [27.6](/filings/0001558370-25-005281.md) | [22.8 d](/filings/0001558370-25-009454.md) | [27.7 d](/filings/0001104659-25-103742.md) | [29.8 d](/filings/0001104659-26-019676.md) | [29.0](/filings/0001104659-26-051523.md) | [31.1 d](/filings/0001104659-26-088152.md) | [86.2 d](/filings/0001104659-25-103742.md) | [44.4 d](/filings/0001104659-26-019676.md) | [42.2](/filings/0001104659-26-051523.md) | [43.9 d](/filings/0001104659-26-088152.md) |
| Capital expenditure | $m | [1.9 d](/filings/0001558370-24-013522.md) | [1.7 d](/filings/0001104659-26-019676.md) | [2.4](/filings/0001558370-25-005281.md) | [1.3 d](/filings/0001558370-25-009454.md) | [1.8 d](/filings/0001104659-25-103742.md) | [2.2 d](/filings/0001104659-26-019676.md) | [1.2](/filings/0001104659-26-051523.md) | [1.4 d](/filings/0001104659-26-088152.md) | [1.0 d](/filings/0001104659-25-103742.md) | [0.5 d](/filings/0001104659-26-019676.md) | [2.0](/filings/0001104659-26-051523.md) | [1.0 d](/filings/0001104659-26-088152.md) |
| Dividends paid | $m | [7.0](/filings/0001558370-24-013522.md) | [7.0 d](/filings/0001104659-26-019676.md) | [7.0](/filings/0001558370-25-005281.md) | [7.0](/filings/0001558370-24-010049.md) | [8.2](/filings/0001558370-24-013522.md) | [8.2 d](/filings/0001104659-26-019676.md) | [8.2](/filings/0001104659-26-051523.md) | [8.1 d](/filings/0001104659-26-088152.md) | [8.1 d](/filings/0001104659-25-103742.md) | [9.2 d](/filings/0001104659-26-019676.md) | [9.2](/filings/0001104659-26-051523.md) | [9.1 d](/filings/0001104659-26-088152.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | [5.7](/filings/0001104659-26-051523.md) | [10.6 d](/filings/0001104659-26-088152.md) | [8.8 d](/filings/0001104659-25-103742.md) | [15.2 d](/filings/0001104659-26-019676.md) | [5.2](/filings/0001104659-26-051523.md) | [32.7 d](/filings/0001104659-26-088152.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [58.8](/filings/0001558370-23-016723.md) | [58.3](/filings/0001558370-24-005603.md) | [58.3](/filings/0001558370-24-010049.md) | [58.3](/filings/0001558370-24-013522.md) | [58.3](/filings/0001558370-25-005281.md) | [58.3](/filings/0001558370-25-009454.md) | [58.4](/filings/0001104659-25-103742.md) | [58.3](/filings/0001104659-26-051523.md) | [58.1](/filings/0001104659-26-088152.md) | [57.9](/filings/0001104659-25-103742.md) | [57.5](/filings/0001104659-26-051523.md) | [57.2](/filings/0001104659-26-088152.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 56,930,451 at 2026-07-27, from the cover of the [10-Q filed 2026-07-29](/filings/0001104659-26-088152.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.